Who
Brian B. Yoor
Director
Company insider
Files Form 4 as: Director, iRhythm Holdings; Executive Vice President & CFO, Abbott Laboratories.
In numbers
- Trades disclosed
- 46
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $49.8M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Jun 2015
- Last trade
- 27 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 29 May 2026 | IRTC iRhythm HoldingsMedical Devices | SEC FORM 4 Code A | —1,573 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | IRTC iRhythm HoldingsMedical Devices | SEC FORM 4 Code A | —1,573 at $0.00 | filing |
| 28 May 2025filed 29 May 2025 | IRTC iRhythm HoldingsMedical Devices | SEC FORM 4 Code A | —1,358 at $0.00 | filing |
| 29 May 2024filed 3 Jun 2024 | IRTC iRhythm HoldingsMedical Devices | SEC FORM 4 Code A | —1,841 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | IRTC iRhythm HoldingsMedical Devices | SEC FORM 4 Code A | —2,399 at $0.00 | filing |
| 28 Feb 2020filed 3 Mar 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $1.1M14,318 at $79.19 | filing |
| 21 Feb 2020filed 25 Feb 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,562 at $0.00 | filing |
| 21 Feb 2020filed 25 Feb 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —14,036 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,229 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —81,709 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —213,470 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —91,121 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —82,321 at $0.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $1.9M41,229 at $47.00 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $4.0M81,709 at $48.90 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $8.2M213,470 at $38.40 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $4.0M91,121 at $44.40 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $4.9M82,321 at $59.94 | filing |
| 28 Jan 2020filed 30 Jan 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $45.7M509,850 at $89.73 | filing |
| 8 Aug 2019filed 9 Aug 2019 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,400 at $0.00 | filing |
News
Abbott Laboratories (NYSE:ABT) Issues Earnings ResultsABT · themarketsdaily.com · 21 Oct 2026Abbott Laboratories Reaffirms FY26 Adj. EPS OutlookABT · rttnews.com · 21 Oct 2026Abbott Laboratories (NYSE:ABT) Given "Buy" Rating at TD CowenABT · dailypolitical.com · 16 Oct 2026
0 headlines in the last 90 days name Brian B. Yoor; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.